Skip to main content

Advertisement

SpringerLink
Log in

Attitudes about prescribing take-home naloxone to injection drug users for the management of heroin overdose: a survey of street-recruited injectors in the San Francisco Bay Area

  • Published:
Journal of Urban Health Aims and scope Submit manuscript

Abstract

Naloxone, an injectable opiate antagonist, can immediately reverse an opiate overdose and prevent overdose death. We sought to determine injection drug users’ (IDUs) attitudes about being prescribed take-home naloxone. During November 1999 to February 2000, we surveyed 82 street-recruited IDUs from the San Francisco Bay Area of California who had experienced one or more heroin overdose events. We used a questiomaire that included structured and open-ended questions. Most respondents (89%) had witnessed an overdose, and 90% reported initially attempting lay remedies in an effort to help companions survive. Only 51% reported soliciting emergency assistance (calling 911) for the last witnessed overdose, with most hesitating due to fear of police involvement. Of IDUs surveyed, 87% were strongly in favor of participating in an overdose management training program to receive take-home naloxone and training in resuscitation techniques. Nevertheless, respontdents expressed a variety of concerning attitudes. If provided naloxone, 35% predicted that they might feel comfortable using greater amounts of heroin, 62% might be less inclined to call 911 for an overdose, 30% might leave an overdose victim after naloxone resuscitation, and 46% might not be able to dissuade the victim from using heroin again to alleviate with drawal symptoms induced by naloxone. Prescribing take-home naloxone to IDUs with training in its use and in resuscitation techniques may represent a life-saving, peer-based adjunct to accessing emergency services. Nevertheless, strategies for overcoming potential risks associated with the use of take-home naloxone would need to be emphasized in an overdose management training program.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Office of National Drug Control Policy. What America’s Users Spend on Illegal Drugs. Washington, DC: Executive Office of the President.; 1997.

    Google Scholar 

  2. Drucker E, Garfield J. Overdose trends in five US citres: 1988–1997. Paper presented at: Preventing Heroin Overdose: Pragmatic Approaches; January 13–14, 2000; Seattle, WA.

  3. Office of Applied Studies (OAS). Year-end Emergency Department Data From the Drug Abuse Warning Network (DAWN). Rockville, MD: Dept of Health and Human Services, Substance Abuse and Mental Health Services Administration; 1999.

    Google Scholar 

  4. San Francisco Medical Examiner. Annual Report. San Francisco, CA: San Francisco Department of Public Health, 1998–1999.

    Google Scholar 

  5. Seal KH, Kral AH, Gee L, et al. Predictors and prevention of nonfatal overdose among street-recruited injection heroin users in the San Francisco Bay Area, 1998–1999. Ann J Public Health. 2001;91:1842–1846.

    Article  CAS  Google Scholar 

  6. Darke S, Ross J, Hall W. Overdose among heroin users in Sydney, Australia: I. Pprevalence and correlates of non-fatal overdose. Addiction. 1996;91:405–411.

    Article  CAS  PubMed  Google Scholar 

  7. Darke S, Zador D. Fatal heroin “overdose”: a review. Addiction. 1996;91:1765–1772.

    Article  CAS  PubMed  Google Scholar 

  8. Zador D, Sunjic S, Darke S. Herbin-related deaths in New South Wales, 1992: toxicological findings and circumstances. Med J Aust. 1996;164:204–207.

    CAS  PubMed  Google Scholar 

  9. Levine B, Green D, Smialek JE. The role of ethanol in heroin deaths. J Forensic Sci. 1995;40:808–810.

    CAS  PubMed  Google Scholar 

  10. Powis B, Strang J, Griffiths P, et al. Self-reported overdose among injecting drug users in London: extent and nature of the problem. Addiction. 1999;94:471–478.

    Article  CAS  PubMed  Google Scholar 

  11. Taylor A, Frischer M, Goldberg D. Non-tatal overdosing is related to polydrug use in Glasgow [letter; comment]. BMJ. 1996;313:1400–1401.

    CAS  PubMed  Google Scholar 

  12. Darke S, Hall W. The distribution of naloxone to heroin users. Addiction. 1997;92:1195–1199.

    Article  CAS  PubMed  Google Scholar 

  13. Sporer KA. Acute heroin overdose. Ann Intern Med. 1999;130:584–590.

    CAS  PubMed  Google Scholar 

  14. Darke S, Ross J, Hall W. Overdose among heroin users in Sydney, Australia: II. responses to overdose. Addiction. 1996;91:413–417.

    Article  CAS  PubMed  Google Scholar 

  15. Strang J, Best D, Man L, Noble A, Gossop M. Peer-mitiated overdose resuscitation: fellow drug users could be mobilized to implement resuscitation. Int J Drug Policy. 2000;11:437–445.

    Article  PubMed  Google Scholar 

  16. Giuliano R. Drug users’ tools of the trade: naloxone and Narcan. Harm Reduction Commun. 1999;9:18–19.

    Google Scholar 

  17. Physician’s Desk Reference. Montevale, NJ: Medical Economics; 2000.

  18. Shulgin A. Controlled Substances: Chemical and Legal Guide to Federal drug Laws. Berkeley, CA: Ronin Publishing, Inc.; 1992.

    Google Scholar 

  19. Goldfrank LR, Hoffman RS. The poisoned patient with altered consciousness. Controversies in the use of a “coma cocktail”. JAMA. 1995;274:562–569.

    Article  PubMed  Google Scholar 

  20. Dettmer K, Naloxone distribution to drug addicts as a contribution to the prevention of opiate overdose fatalities. Paper presented at: Preventing Heroin overdose: Pragmatic Approaches; January 13–14, 2000; Seattle, WA.

  21. Ronconi S. Prevention of overdoses among current heroin users in Torino, Italy, for the period 1995–1998. Paper presented at: Preventing Heroin Overdose: Pragmatic Approaches; January 13–14, 2000; Seattle, WA.

  22. Bigg D.. Dats on take home naloxone are unclear but not condemnatory [letter]. BMJ. 2002;324:678.

    Article  PubMed  Google Scholar 

  23. Strang J, Powis B, Best D, et al. Preventing opiate overdose fatalities with take-home naloxone: pre-launch study of possible impact and acceptability. Addiction, 1999;94:199–204.

    Article  CAS  PubMed  Google Scholar 

  24. Lenton SR, Hargreaves KM. Should we conduct a trial of distributing naloxone to heroin users for peer administration to prevent fatal overdose? Med J Aust. 2000;173:260–263.

    CAS  PubMed  Google Scholar 

  25. Watters JK. Trends in risk behavior and HIV seroprevalence in heterosexual injection drug users in San Francisco, 1986–1992. J Acquir Immune Defic Syndr. 1994;7:1276–1281.

    CAS  PubMed  Google Scholar 

  26. Kral AH, Bluthenthal RN, Lorvick J, Gee L, Bacchetti P, Edlin BR. Sexual transmission of HIV-1 among injection drug users in San Francisco, USA: risk-factor analysis. Lancet. 2001;357:1397–1401.

    Article  CAS  PubMed  Google Scholar 

  27. Watters JK, Biernacki P. Targeted sampling: options for the study of hidden populations. Soc Problems. 1989;36:416–430.

    Google Scholar 

  28. Bluthenthal RN, Watters JK. Multimethod research: from targeted sampling to HIV risk behaviors. In: Lambert EY, Ashery RS, Needle RH, eds. Qualitative Methods in the Prevention of Drug Abuse and HIV Research. Vol. 157. Rockville, MD: National Institute on Drug Abuse; 1995:212–230.

    Google Scholar 

  29. Darke S, Hall W, Weatherburn D, Lind B. Fluctuations in heroin purity and the incidence of fatal heroin overdose. Drug Alcohol Depend. 1999;54:155–161.

    Article  CAS  PubMed  Google Scholar 

  30. Bammer G, Sengoz A. Non-fatal heroin overdoses [letter]. Med J Aust 1994;161:572–573.

    CAS  PubMed  Google Scholar 

  31. Gossop M, Griffiths P, Powis B, Williamson S, Strang J. Frequency of non-fatal heroin overdose: survey of heroin users recruited in non-clinical settings. BMJ. 1996;313:402.

    CAS  PubMed  Google Scholar 

  32. Levy JA, Gallmeier CP, Weibel WW. The outreach assisted peer-support model for controlling drug dependency. J Drug Issues. 1995;25:507–529.

    Google Scholar 

  33. Hawkins WE, Latkin C, Mandel W, Oziemkowska M. Do actions speak louder than words? Perceived peer influences on needle sharing and cleaning in a sample of injection drug users. AIDS Educ Prev. 1999;11:122–131.

    CAS  PubMed  Google Scholar 

  34. Broadhead RS, Heckathorn DD, Weakliem DL, et al.. Hernessing peer networks as an instrument for AIDS prevention: results from a peer-driven intervention. Public Health Rep. 1998;113(Suppl 1):42–57.

    PubMed  Google Scholar 

  35. Burris S, Noreland J, Edlin B. Legal aspects of providing naloxone to heroin users in the United States. Int J Drug Policy. 2001;12:237–248.

    Article  Google Scholar 

  36. Sporer KA, Firestone J, Isaacs SM. Out of-hospital treatment of opioid overdoses in an urban setting. Acad Emerg Med. 1996;3:660–667.

    Article  CAS  PubMed  Google Scholar 

  37. Smith DA, Leake L, Loflin JR, Yealy DM. Is admission after intravenous heroin overdose necessary? Ann Emerg Med. 1992;21:1326–1330.

    Article  CAS  PubMed  Google Scholar 

  38. Vilke GM, Buchanan J, Dunford JV, Chan TC. Are heroin overdose deaths related to patient release after prehospital treatment with naloxone? Prehosp Emerg Care. 1999;3:183–186.

    CAS  PubMed  Google Scholar 

  39. Centers for Disease Control and Prevention. Unintentional overdose in King County, Washington, 1990–1999. MMWR Morb Mortal Wkly Rep. 2000;49:633–636.

    Google Scholar 

  40. Centers for Disease Control and Prevention. Herbin overdose deaths—Multnomah County, Oregon, 1993–1999. MMWR Morb Mortal Wkly Rep. 2000;49:633–636.

    Google Scholar 

  41. Watters JK, Needle R, Brown BS, Weatherby N, Booth R, Williams M. The self-reporting of cocaine use. JAMA. 1992;268:2374–2375; [discussion], 2375–2376.

    Article  CAS  PubMed  Google Scholar 

  42. Dowling-Guyer S, Johnson ME, Fisher DG, et al. Relability of drug user’s self-reported HIV risk behaviors and validity of self-reported recent drug use. Assessment. 1994;1:383–392.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Urban Health Study, Department of Family and Community Medicine, University of California, San Francisco, 3180 18th Street, Suite 302, 94110, San Francisco, CA

    Karen H. Seal, Moher Downing, Alex H. Kral, Shannon Singleton-Banks, Jon-Paul Hammond, Jennifer Lorvick, Dan Ciccarone & Brian R. Edlin

Authors
  1. Karen H. Seal
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Moher Downing
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Alex H. Kral
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Shannon Singleton-Banks
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Jon-Paul Hammond
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Jennifer Lorvick
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Dan Ciccarone
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Brian R. Edlin
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Karen H. Seal.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Seal, K.H., Downing, M., Kral, A.H. et al. Attitudes about prescribing take-home naloxone to injection drug users for the management of heroin overdose: a survey of street-recruited injectors in the San Francisco Bay Area. J Urban Health 80, 291–301 (2003). https://doi.org/10.1093/jurban/jtg032

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1093/jurban/jtg032

Keywords

Search

Navigation